IgA-mediated epidermolysis bullosa acquisita: Two cases and review of the literature

被引:57
|
作者
Vodegel, RM [1 ]
de Jong, MCJM [1 ]
Pas, HH [1 ]
Jonkman, MF [1 ]
机构
[1] Univ Groningen Hosp, Dept Dermatol, Ctr Blistering Skin Dis, NL-9700 RB Groningen, Netherlands
关键词
D O I
10.1067/mjd.2002.125079
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
We describe 2 adult patients with a subepidermal bullous dermatosis with exclusively linear IgA depositions along the epidermal basement membrane zone that were deposited in the sublamina densa zone as witnessed by direct immunoelectron microscopy. Indirect immunofluorescence microscopy of patients' sera revealed circulating IgA autoantibodies that bound exclusively to the dermal site of salt-split skin substrate. Immunoblot analysis using dermal and keratinocyte extracts were negative. Indirect immunofluorescence microscopy using type VII collagen-deficient skin ("knockout" substrate) showed no IgA binding, whereas linear IgA binding was seen at the epidermal basement membrane zone in normal human skin. The autoantigen in the patients was thus type VII collagen. A diagnosis of IgA-mediated epidermolysis bullosa acquisita (IgA-EBA) was made. We systematically reviewed the literature of this subset of patients with linear IgA dermatosis on the basis of the following criteria: exclusive binding of serum-IgA to the dermal side of salt-split skin or IgA depositions in the sublamina densa zone by indirect or direct immunoelectron microscopy. We learned that IgA-EBA is clinically indistinguishable from the classic "lamina-lucida type" linear IgA dermatosis or from the inflammatory type of IgG-mediated epidermolysis bullosa acquisita (IgG-EBA). Only a minority of the patients with IgA-EBA showed milia or scarring or had therapy-resistant ocular symptoms as in the mechanobullous type of IgG-EBA. Most patients with IgA-EBA responded to dapsone therapy.
引用
收藏
页码:919 / 925
页数:7
相关论文
共 50 条
  • [1] First experience with adalimumab for two variants of linear IgA disease (LAD): classic LAD and IgA-mediated epidermolysis bullosa acquisita
    Blok, J. L.
    Jonkman, M. F.
    Horvath, B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S62 - S62
  • [2] Epidermolysis bullosa acquisita: Literature review
    Le Roux-Villet, C.
    Prost-Squarcioni, C.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2011, 138 (03): : 228 - 246
  • [3] CHILDHOOD EPIDERMOLYSIS-BULLOSA ACQUISITA - REPORT OF 3 CASES AND REVIEW OF LITERATURE
    ARPEY, CJ
    ELEWSKI, BE
    MORITZ, DK
    GAMMON, WR
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1991, 24 (05) : 706 - 714
  • [4] The use of rituximab in treatment of epidermolysis bullosa acquisita: Three new cases and a review of the literature
    Bevans, Stephanie L.
    Sami, Naveed
    DERMATOLOGIC THERAPY, 2018, 31 (06)
  • [5] Epidermolysis bullosa acquisita and inflammatory bowel disease: a review of the literature
    Reddy, H.
    Shipman, A. R.
    Wojnarowska, F.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2013, 38 (03) : 225 - 230
  • [6] IgA- Epidermolysis bullosa acquisita - a Case Report
    Peters, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 4 - 4
  • [7] Ocular involvement in IgA-epidermolysis bullosa acquisita
    Bauer, JW
    Schaeppi, H
    Metze, D
    Muss, W
    Pohla-Gubo, G
    Hametner, R
    Ruckhofer, J
    Grabner, G
    Hintner, H
    BRITISH JOURNAL OF DERMATOLOGY, 1999, 141 (05) : 887 - 892
  • [8] IGA epidermolysis bullosa acquisita during pregnancy.
    Aronson, IK
    Gruber, DM
    Kumar, R
    Chen, M
    Traczyk, T
    Woodley, DT
    Chan, LS
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 516 - 516
  • [9] Epidermolysis bullosa acquisita: Update and review
    Hallel-Halevy, D
    Nadelman, C
    Chen, M
    Woodley, DT
    CLINICS IN DERMATOLOGY, 2001, 19 (06) : 712 - 718
  • [10] Evaluation and Comparison of Clinical and Laboratory Characterstics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita
    Becker, Mareike
    Schumacher, Nina
    Schmidt, Enno
    Zillikens, Detlef
    Sadik, Christian D.
    JAMA DERMATOLOGY, 2021, 157 (08) : 917 - 923